HealthSource review

What it is

HealthSource is a telehealth weight-management and wellness platform selling compounded semaglutide with B12 in vial form, injectable compounded tirzepatide and an oral sublingual tirzepatide tablet, alongside a wellness line covering sermorelin, NAD⁺ injection, NAD⁺ nasal spray, glutathione injection and a product called Bio Protein Plus, plus sexual-health and beauty items. Medication is dispensed through what it describes as a US-based FDA 503A licensed partner pharmacy and shipped directly within three to five business days. It states availability in all 50 states, and its programs cover medication, supplies and a telehealth visit with board-certified physicians.

How it works

A WooCommerce storefront over a telehealth visit, with each program bundling the medication, the supplies and the clinician visit into one recurring charge and adding unlimited provider messaging through a HIPAA-compliant platform with around-the-clock care-team access. Unlimited messaging is a real inclusion rather than a slogan when you are titrating an injectable, and the platform's stated auto-refund if a required monthly reassessment is not completed is an unusual and patient-protective mechanic — it means an unmonitored subscription does not quietly keep billing. Against that, no individual clinician is named anywhere, only "board-certified physicians" as a category, and no medical director or clinical leadership is disclosed. No LegitScript certification was found. The 503A partner pharmacy is disclosed as a category but never named. And labs are not mentioned on any product page, so there is no baseline bloodwork protocol before a growth-hormone-axis peptide.

Pricing transparency

Published for every product, which is the case for listing it, with one structural caveat that matters more than it looks. Sermorelin is $295 every four weeks. NAD⁺ injection is from $279 every four weeks and the NAD⁺ nasal spray $179 on the same cycle. Glutathione injection is $180 every four weeks. On the weight-loss side, compounded semaglutide is from $199, injectable tirzepatide from $299 and oral sublingual tirzepatide from $399, all every four weeks. A four-week cycle produces thirteen charges in a year rather than twelve, so multiply accordingly before comparing these against a provider quoting a calendar month — that is why we have not carried these figures into the numeric price field. The "from" framing is the second caveat: multiple dose tiers exist per product, described as starter and full-dose options, so the entry figure is the lowest tier rather than what a maintenance dose costs. Ask what the full-dose price is for the specific product before enrolling.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. HealthSource describes its medications as dispensed through a US-based FDA 503A licensed partner pharmacy but does not name it, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. The compounded status of the oral sublingual tirzepatide is not explicitly labelled on the site either, though the 503A model and the sublingual tablet form are consistent with it — that is an inference worth confirming rather than assuming. On the evidence, the three wellness products this board cares about sit on different footings. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism whose long-term human outcome data stays thin, with no controlled trial behind the anti-aging claims the line is marketed under. Injected and intranasal NAD⁺ have no controlled human outcome trials; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly, and the studied forms are the oral precursors NR and NMN, which raise blood NAD⁺ rather than demonstrate a clinical outcome. Injectable glutathione has essentially no controlled human outcome evidence. Individual results vary.

Pros and watch-outs

The evidence behind what HealthSource prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How HealthSource compares

A few alternatives worth a look, depending on what you’re optimizing for.

• CoreAge Rx

  Injected or intranasal NAD⁺ at a published price across 50 states

  See CoreAge Rx →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →
• Telos RX

  Choice of GLP-1 formats, including needle-free sublingual tirzepatide

  See Telos RX →